Rheumatology News

Tofacitinib’s benefits in patients with juvenile idiopathic arthritis extend through at least 48 months, with no new safety findings, according to data published in Annals of the Rheumatic Diseases.

A 15-day course of Paxlovid demonstrated no significant benefit for patients with post-acute sequelae of SARS-CoV-2 infection, according to data published in JAMA Internal Medicine.

Bloomberg Philanthropies announced that it has donated $1 billion to make Johns Hopkins University’s medical school free for most of its students seeking an MD.

Men are more than twice as likely than women to develop IgG4-related disease, and demonstrate “striking” sex-dependent organ distribution and B-cell response, according to data published in The Lancet Rheumatology.

New EULAR classification criteria for hand osteoarthritis — including age, morning stiffness duration, radiographic osteophytes and radiographic joint space narrowing — feature separate criteria for thumb base and interphalangeal OA.

Like many sports, such as soccer and basketball, financial independence requires simultaneous offense and defense. One of the most important defensive plays a physician must make is buying disability insurance.

Individuals who follow a diet of healthy plant foods demonstrate a lower risk for gout, while those with a greater intake of unhealthy plant foods had a higher risk, according to data published in JAMA Network Open.

Patients with long COVID symptoms demonstrate elevated levels of several inflammatory molecules — findings that could have important implications in both rheumatology and the search for a potential treatment for long COVID.

Belimumab substantially increases circulating memory B-cells in patients with systemic lupus erythematosus, potentially enabling “a more efficient targeting of the B-cell compartment,” according to data published in Rheumatology.

Makeup not only has cosmetic applications, but medical ones too.